A detailed history of Pdt Partners, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 23,701 shares of ATRC stock, worth $728,094. This represents 0.06% of its overall portfolio holdings.

Number of Shares
23,701
Holding current value
$728,094
% of portfolio
0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$20.34 - $29.5 $482,078 - $699,179
23,701 New
23,701 $664,000
Q4 2022

Feb 14, 2023

BUY
$33.48 - $47.45 $314,645 - $445,935
9,398 Added 54.51%
26,638 $1.18 Million
Q3 2022

Nov 14, 2022

SELL
$38.25 - $52.62 $551,106 - $758,148
-14,408 Reduced 45.53%
17,240 $674,000
Q2 2022

Aug 15, 2022

BUY
$35.1 - $66.01 $988,767 - $1.86 Million
28,170 Added 809.95%
31,648 $1.29 Million
Q1 2022

May 16, 2022

BUY
$57.43 - $71.39 $199,741 - $248,294
3,478 New
3,478 $228,000
Q4 2020

Feb 16, 2021

SELL
$34.56 - $57.55 $341,280 - $568,306
-9,875 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$38.36 - $46.91 $378,805 - $463,236
9,875 New
9,875 $394,000
Q2 2019

Aug 14, 2019

SELL
$26.85 - $30.74 $618,382 - $707,972
-23,031 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$26.38 - $33.34 $91,960 - $116,223
-3,486 Reduced 13.15%
23,031 $617,000
Q4 2018

Feb 14, 2019

SELL
$26.66 - $34.85 $172,836 - $225,932
-6,483 Reduced 19.65%
26,517 $811,000
Q3 2018

Nov 14, 2018

SELL
$27.62 - $35.58 $273,438 - $352,242
-9,900 Reduced 23.08%
33,000 $1.16 Million
Q2 2018

Aug 14, 2018

SELL
$19.65 - $30.28 $368,830 - $568,355
-18,770 Reduced 30.44%
42,900 $1.16 Million
Q1 2018

May 15, 2018

SELL
$15.05 - $21.03 $70,674 - $98,756
-4,696 Reduced 7.08%
61,670 $1.27 Million
Q4 2017

Feb 14, 2018

BUY
$17.69 - $23.44 $12,754 - $16,900
721 Added 1.1%
66,366 $1.21 Million
Q3 2017

Nov 14, 2017

BUY
$20.0 - $24.23 $1.31 Million - $1.59 Million
65,645
65,645 $1.47 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.